SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-19-000025
Filing Date
2019-08-09
Accepted
2019-08-09 11:02:54
Documents
89
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20190630x10q.htm   iXBRL 10-Q 1540824
2 EXHIBIT 31.1 supn-20190630x10qxex311.htm EX-31.1 11965
3 EXHIBIT 31.2 supn-20190630x10qxex312.htm EX-31.2 12727
4 EXHIBIT 32.1 supn-20190630x10qxex321.htm EX-32.1 5885
5 EXHIBIT 32.2 supn-20190630x10qxex322.htm EX-32.2 5911
11 JPG currentportfolio2q19.jpg GRAPHIC 43253
  Complete submission text file 0001356576-19-000025.txt   6992079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20190630.xsd EX-101.SCH 52093
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20190630_cal.xml EX-101.CAL 101482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20190630_def.xml EX-101.DEF 188745
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20190630_lab.xml EX-101.LAB 631596
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20190630_pre.xml EX-101.PRE 360038
12 EXTRACTED XBRL INSTANCE DOCUMENT supn-20190630x10q_htm.xml XML 1158855
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 191011862
SIC: 2834 Pharmaceutical Preparations